Brigit Biofarmaka Teknologi Tbk. vs Perintis Triniti Properti Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume), while Perintis Triniti Properti Tbk. trades at Rp298 (market cap 1.36T, 1.31M 24h volume). The key difference: Perintis Triniti Properti Tbk. is far larger — about 8.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Perintis Triniti Properti Tbk. is more actively traded (1.31M versus 43.9K). Which is the better fit depends on your goals.
| OBAT | TRIN | |
|---|---|---|
Market Cap | 164.65B | 1.36T |
Volume | 43.9K | 1.31M |
Lot | 439 | 13.13K |
Turnover | 10.6M | 386.52M |
Average Price | 241.43 | 294.4 |
Value | 10.6M | 386.52M |
Indicative Equilibrium Price | 238 | 302 |
Indicative Equilibrium Volume | 100 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Perintis Triniti Properti Tbk (the Company) was established dated March 13, 2009 based on Notarial Deed No. 06 of Drs. Arif Djohan Tunggal, S.H., M.H., M.Kn., Notary in Jakarta.
Read more on TRIN →